BioXcel Therapeutics (BTAI) Stock Chart & Stock Price History $4.04 +0.63 (+18.48%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$4.20 +0.16 (+3.96%) As of 08/8/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BioXcel Therapeutics Stock Price Performance The BioXcel Therapeutics (BTAI) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 65.46%, with a year-to-date return of -32.47%. In the past month, the stock has increased 102.00%, reflecting recent market activity. As of the latest close, BioXcel Therapeutics traded at $4.04 with a market cap of $24.48 million and volume of 43.03 million shares. Five years ago, the stock traded at a split-adjusted price of $722.72, representing a 99.44% decrease over that period. At the time, it had a market cap of $912.89 million and a volume of 33,850 shares. Receive BTAI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BioXcel Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+36.03%1 Month Performance+102.00%3 Month Performance+164.05%Year-To-Date Performance-32.47%1 Year Performance-65.46%5 Year Performance-99.44% BTAI Stock Chart for Sunday, August, 10, 2025 BTAI Chart by TradingView BioXcel Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/08/2025$3.41$4.04+18.48%$4.68$3.5743.03 million shs$24.48 million08/07/2025$3.32$3.41+2.71%$3.70$3.0614.60 million shs$20.65 million08/06/2025$2.97$3.32+11.78%$3.84$2.9848.74 million shs$20.12 million08/05/2025$2.54$2.97+16.93%$3.48$2.2639.77 million shs$18.00 million08/04/2025$1.37$2.54+85.40%$2.75$1.5881.09 million shs$15.38 million08/01/2025$1.31$1.37+4.58%$2.07$1.33109.14 million shs$8.30 million07/31/2025$1.43$1.31-8.39%$1.51$1.30429,478 shs$7.94 million07/30/2025$1.59$1.43-10.06%$1.59$1.39387,700 shs$8.67 million07/29/2025$1.70$1.59-6.47%$1.76$1.57282,250 shs$9.63 million07/28/2025$1.81$1.70-6.08%$1.82$1.65351,003 shs$10.30 million Get the Latest News and Ratings for BTAI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioXcel Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/25/2025$1.73$1.81+4.62%$1.83$1.75213,740 shs$10.97 million07/24/2025$1.81$1.73-4.42%$1.80$1.70334,500 shs$10.48 million07/23/2025$1.81$1.81+0.28%$1.87$1.75372,050 shs$10.97 million07/22/2025$1.89$1.81-4.50%$1.92$1.74384,233 shs$10.94 million07/21/2025$1.91$1.89-1.05%$1.95$1.88263,511 shs$11.45 million07/18/2025$1.94$1.91-1.55%$2.00$1.87175,196 shs$11.58 million07/17/2025$1.95$1.94-0.51%$1.98$1.87279,911 shs$11.76 million07/16/2025$1.90$1.95+2.63%$2.01$1.86288,557 shs$11.81 million07/15/2025$2.02$1.90-5.94%$2.27$1.881.40 million shs$11.51 million07/14/2025$1.97$2.02+2.54%$2.07$1.90274,253 shs$12.24 million07/11/2025$2.00$1.97-1.50%$2.06$1.91140,279 shs$11.94 million07/10/2025$2.00$2.00$2.15$1.99300,875 shs$12.11 million07/09/2025$2.01$2.00-0.50%$2.10$1.96297,153 shs$12.12 million07/08/2025$1.90$2.01+5.79%$2.03$1.81293,004 shs$12.18 million Related Companies Mersana Therapeutics Stock Price Chart Akari Therapeutics Stock Price Chart Mana Capital Acquisition Stock Price Chart Estrella Immunopharma Stock Price Chart Synergy CHC Stock Price Chart Iterum Therapeutics Stock Price Chart Dyadic International Stock Price Chart Clearside Biomedical Stock Price Chart OnKure Therapeutics Stock Price Chart Kezar Life Sciences Stock Price Chart Receive BTAI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BioXcel Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BTAI) was last updated on 8/10/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAltucher: $900 to $108,000? Trump’s “Great Gain” Is HereJames Altucher says two recent events could trigger a historic wealth shift—one driven by a radical Trump poli...Paradigm Press | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 17th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioXcel Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioXcel Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
